7.1 Club score Visit nvidia.com
Plans
Every plan and priceBioNeMo Framework Community Resource
Free
What the maker publishes
- Access
- Pretrained models can be accessed through cloud APIs or a web interface for interactive inference, visualization, and experimentation. source
- Documentation status
- BioNeMo Framework documentation is being refactored as NVIDIA consolidates parallelism-training code with BioNeMo Recipes. source
- Drug discovery applications
- The product supports model customization and deployment for protein structure prediction, molecule generation, property prediction, and molecular docking. source
- Early access
- The BioNeMo product page directs visitors to apply for early access. source
- Enterprise support
- NVIDIA says an enterprise license is available for improved expert-level support. source
- Framework scope
- BioNeMo Framework is a collection of programming tools, libraries, and models for computational drug discovery. source
- GPU requirement
- BioNeMo Recipes require an environment with access to NVIDIA GPUs; bfloat16 requires Ampere-generation GPUs or newer. source
- Intended audience
- NVIDIA presents BioNeMo as a tool for researchers and developers working on AI-powered drug discovery. source
- Models
- The documentation lists Amplify, Evo2, Geneformer, and ESM 2 among the framework models. source
- Performance and integration
- The framework provides optimized models and tooling designed to integrate with GPU-based computational resources. source
- Purpose
- BioNeMo is a generative AI platform for drug discovery that supports training models on users’ own data and scalable model deployment. source
- Training infrastructure
- NVIDIA describes training and optimization using DGX Cloud, its multi-node AI training-as-a-service solution. source
- Unsupported GPU use
- Running BioNeMo without bfloat16 may be possible, but the development team does not support that use case. source
Checked against the maker's pages on 14 Nov 2026.